Immunoadsorption apheresis (Selesorb ©) in the treatment of chronic hepatitis C virus-related type 2 mixed cryoglobulinemia

Transfusion and Apheresis Science

Volumn 28, Issue 3, 2003, Pages 207-214

  Stefanutti, C ^a   Di Giacomo, S ^a   Mareri, M ^a   De Lorenzo, F ^a   D'Alessandri, G ^b   Angelico, F ^a   Bucci, A ^a   Musca, A ^a   Mammarella, A ^a  

^a POLICLINICO UMBERTO I   (Italy)

^b Azienda USL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULOSE DERIVATIVE; DEXTRAN SULFATE CELLULOSE; SELESORB; UNCLASSIFIED DRUG;

ADULT; AGED; APHERESIS; ARTICLE; CLINICAL TRIAL; CRYOGLOBULINEMIA; DRUG EFFICACY; FEMALE; HEPATITIS C VIRUS; HUMAN; IMMUNOADSORBENT; IMMUNOADSORPTION; NEUROPATHY; PLASMAPHERESIS; TREATMENT OUTCOME; VASCULITIS;

EID: 0037410051     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-0502(03)00055-7     Document Type: Article

References (45)

1. Petersen J. Essential cryoglobulinaemia: a clinical course lasting 25 years. Scand. J. Haematol. 35(5):1985;501-504.
2. Agnello V. Mixed cryoglobulinemia and hepatitis C virus. Hosp. Pract. 30(3):1995;35-42.
3. Eng M.A., Kallemuchikkal U., Gorevic P.D. Hepatitis C virus, autoimmunity and lymphoproliferation. Mt. Sinai J. Med. 67(2):2000;120-132. Review.
4. Garcia de La Pena Lefebvre P., Mouthon L., Cohen P., Lhote F., Guillevin L. Polyarteritis nodosa and mixed cryoglobulinaemia related to hepatitis B and C virus coinfection. Ann. Rheum. Dis. 60(1):2001;1068-1069.
5. Stricker R.B., Sanders K.A., Owen W.F., Kiprov D.D., Miller R.G. Mononeuritis multiplex associated with cryoglobulinemia in HIV infection. Neurology. 42(11):1992;2103-2105.
6. Voll C., Ang L.C., Sibley J., Card R., Lefevre K. Polymyositis with plasma cell infiltrate in essential mixed cryoglobulinaemia. J. Neurol. Neurosurg. Psychiatry. 56(3):1993;317-318.
7. Weber M., Kohler H., Fries J., Thoenes W., Meyer zum Buschenfelde K.H. Rapidly progressive glomerulonephritis in IgA/IgG cryoglobulinemia. Nephron. 41(3):1985;258-261.
8. Geltner D., Kohn R.W., Gorevic P., Franklin E.C. The effect of combination therapy (steroids, immunosuppressives, and plasmapheresis) on 5 mixed cryoglobulinemia patients with renal, neurologic, and vascular involvement. Arthritis Rheum. 24(9):1981;1121-1127.
9. Ballare M., Bobbio F., Poggi S., Bordin G., Bertoncelli M.C., Catania E.et al. A pilot study on the effectiveness of cyclosporine in type II mixed cryoglobulinemia. Clin. Exp. Rheumatol. 13(Suppl 13):1995;S201-S203.
10. Tavoni A., Mosca M., Ferri C., Moriconi L., La Civita L., Lombardini F.et al. Guidelines for the management of essential mixed cryoglobulinemia. Clin. Exp. Rheumatol. 13(Suppl 13):1995;S191-S195. Review.
11. Siami G.A., Siami F.S. Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenstrom's macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis. Ther. Apher. 3(1):1999;8-19. Review.
12. Delaney V.B., Fraley D.S., Segal D.P., Bruns F.J. Plasmapheresis as sole therapy in a patient with essential mixed cryoglobulinemia. Am J. Kidney Dis. 4(1):1984;75-77.
13. Berkman E.M., Orlin J.B. Use of plasmapheresis and partial plasma exchange in the management of patients with cryoglobulinemia. Transfusion. 20(2):1980;171-178.
14. Dominguez J.H., Sha E. Apheresis in cryoglobulinemia complicating hepatitis C and in other renal diseases. Ther. Apher. 6(1):2002;69-76. Review.
15. Lamprecht P., Gause A., Gross W.L. Cryoglobulinemic vasculitis resistant to intermittent intravenous pulse cyclophosphamide therapy. Scand. J. Rheumatol. 29(3):2000;201-202.
16. Braun N., Bosch T. Immunoadsorption, current status and future developments. Expert Opin. Investig. Drugs. 9(9):2000;2017-2038.
17. Schneider K.M. Plasmapheresis and immunoadsorption: different techniques and their current role in medical therapy. Kidney Int. Suppl. 64:1998;S61-S65. Review.
18. Finsterer J., Derfler K. Immunoadsorption in multifocal motor neuropathy. J. Immunother. 22(5):1999;441-502.
19. Toepfer M., Schiffl H., Sitter T., Pongratz D., Muller-Felber W. Extracorporeal antibody elimination in neuroimmunological diseases. Ther. Apher. 3(3):1999;268-270.
20. Nakaji S. Current topics on immunoadsorption therapy. Ther. Apher. 5(4):2001;301-305.
21. Klein H.G., Balow J.E., Dau P.C., Hamburger M.I., Leitman S.F., Pineda A.A.et al. Clinical applications of therapeutic apheresis. Report of the Clinical Applications Committee, American Society for Apheresis. J. Clin. Apheresis. 3(1):1986;1-92.
22. Suzuki K. The role of immunoadsorption using dextran-sulfate cellulose columns in the treatment of systemic lupus erythematosus. Ther. Apher. 4(3):2000;239-243.
23. Hidaka T., Suzuki K., Matsuki Y., Takamizawa-Matsumoto M., Kataharada K., Ishizuka T.et al. Evaluation of adsorption selectivity dextran sulfate bound cellulose beads for the removal of anti-DNA antibodies. Ther. Apher. 3(1):1999;75-80.
24. Inoue A., Oguchi K., Iwahashi T., Arakura H., Koh C.S. Prominent effects of immunoadsorption plasmapheresis therapy in a patient with chronic inflammatory demyelinating polyneuropathy associated with hepatitis B infection. Ther. Apher. 2(4):1998;305-307.
25. McLeod B.C., Sassetti R.J. Plasmapheresis with return of cryoglobulin-depleted autologous plasma (cryoglobulinpheresis) in cryoglobulinemia. Blood. 55(5):1980;866-870.
26. Corvetta A., Marchegiani G., Salvi A., Chirelli P.A., Danieli G. Immune complexes and complement profile in essential mixed cryoglobulinemia before and after plasma exchange. Int. J. Artif. Organs. 6(Suppl 1):1983;65-68.
27. Siami G.A., Siami F.S., Ferguson P., Stone W.J., Zborowski M. Cryofiltration apheresis for treatment of cryoglobulinemia associated with hepatitis C. ASAIO J. 41(3):1995;M315-M318.
28. Kiyomoto H., Hitomi H., Hosotani Y., Hashimoto M., Uchida K., Kurokouchi K.et al. The effect of combination therapy with interferon and cryofiltration on mesangial proliferative glomerulonephritis originating from mixed cryoglobulinemia in chronic hepatitis C virus infection. Ther. Apher. 3(4):1999;329-333.
29. Schott P., Hartmann H., Ramadori G. Hepatitis C virus-associated mixed cryoglobulinemia. Clinical manifestations, histopathological changes, mechanisms of cryoprecipitation and options of treatment. Histol. Histopathol. 16(4):2001;1275-1285. Review.
30. Siami G.A., Siami F.S. Current topics on cryofiltration technologies. Ther. Apher. 5(4):2001;283-286. Review.
31. Drew M.J. Plasmapheresis in the dysproteinemias. Ther. Apher. 6(1):2002;45-52. Review.
32. Dammacco F., Sansonno D., Han J.H., Shyamala V., Cornacchiulo V., Iacobelli A.R.et al. Natural interferon-alpha versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term, randomized, controlled study. Blood. 84(10):1994;3336-3343.
33. Siami G.A., Siami F.S. Intensive tandem cryofiltration apheresis and hemodialysis to treat a patient with severe calciphylaxis, cryoglobulinemia, and end-stage renal disease. ASAIO J. 45(3):1999;229-233.
34. Keller F., Wagner K., Faber U., Scholle J., Neumayer H.H., Maiga M.et al. Elimination kinetics of plasma exchange. Klin. Wochenschr. 61:1983;1115-1122.
35. Schneider K.M. Plasmapheresis and immunoadsorption: different techniques and their current role in medical therapy. Kidney Int. Suppl. 64:1998;S61-S65.
36. Lewis E.J. Plasmapheresis in collagen vascular diseases. Ther. Apher. 3(2):1999;172-177.
37. Waldenstrom J.G., Raiend U. Plasmapheresis and cold sensitivity of immunoglobulin molecules. I. A study of hyperviscosity, cryoglobulinemia, euglobulinemia and macroglobulinemia vera. Acta Med. Scand. 216(5):1984;449-466.
38. Shaw M., Van de Pette J., Fenton D., McGibbon D.H. Mutilating cryoglobulinaemia rapidly improved by plasmapheresis: diagnostic features on blood film. J. R. Soc. Med. 78(Suppl 11):1985;37-39.
39. Yamashita M., Malchesky P.S., Omokawa S., Horiuchi T., Zborowski M., Koo A.P.et al. Limitation of plasmapheresis in cryoglobulinemia with high levels of cryoglobulins. Prog. Clin. Biol. Res. 337:1990;491-494.
40. Ohshima T., Sawada K., Tanaka J., Zborowski M., Koo A.P., Malchesky P.S. Do humoral factors removed by plasmapheresis suppress the cellular immune system in cryoglobulinemia. ASAIO Trans. 37(3):1991;M431-M433.
41. Siami G.A., Wilkins W., Stone W.J., Koo A.P., Zborowski M. Clinical trials of a cryoglobulin filter. ASAIO J. 40(3):1994;M658-M662.
42. Siami F.S., Siami G.A. Cryofiltration apheresis in the treatment of cryoprecipitate induced diseases. Ther. Apher. 1(1):1997;58-62.
43. Russo G.E., Caramiello M.S., Vitaliano E., De Marco C.M., Pennacchia M., Giusti S.et al. Haemorheological changes in mixed cryoglobulinaemia during apheresis treatment. Transfus. Sci. 17(4):1996;499-503.
44. Felson D.T., LaValley M.P., Baldassare A.R., Block J.A., Caldwell J.R., Cannon G.W.et al. The Prosorba column for treatment of refractory rheumatoid arthritis: a randomized, double-blind, sham-controlled trial. Arthritis Rheum. 42:1999;2153-2159.
45. Siami G.A., Siami F.S. Cryofiltration apheresis in the United States. Ther. Apher. 2(3):1998;228-235.